Telogen effluvium, or temporary hair loss, has been reported in COVID-19 patients who live in low-income minority communities, according to a study recently published in the Journal of the American Academy of Dermatology

Dermatologists saw a 400 percent uptick in telogen effluvium cases approximately three months after New York City announced their shelter-in-place directive, which is the typical time frame that shedding occurs after experiencing extreme stress. “The surge in cases of hair loss we are treating now is a delayed consequence of the illness and anxiety experienced by these predominantly minority communities during the first wave of COVID-19 in NYC,” said Shoshana Marmon, MD, PhD, assistant clinical professor of dermatology at New York Medical College. 

According to Dr. Marmon, hair loss is a common symptom of coronavirus ‘long-haulers’ and that it’s important to track patients struggling with telogen effluvium to determine if it’s temporary or symptomatic of something more serious. 



Please enter your comment!
Please enter your name here